NovoCure Ltd (NVCR)
22.17
+1.12
(+5.32%)
USD |
NASDAQ |
May 16, 16:00
22.18
+0.02
(+0.07%)
After-Hours: 20:00
NovoCure Total Liabilities (Quarterly): 762.07M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 762.07M |
December 31, 2023 | 783.63M |
September 30, 2023 | 752.65M |
June 30, 2023 | 743.33M |
March 31, 2023 | 742.19M |
December 31, 2022 | 750.48M |
September 30, 2022 | 728.81M |
June 30, 2022 | 721.00M |
March 31, 2022 | 714.33M |
December 31, 2021 | 729.00M |
September 30, 2021 | 707.29M |
June 30, 2021 | 699.79M |
March 31, 2021 | 695.50M |
December 31, 2020 | 575.46M |
September 30, 2020 | 124.01M |
June 30, 2020 | 261.12M |
March 31, 2020 | 260.50M |
December 31, 2019 | 261.66M |
September 30, 2019 | 253.49M |
Date | Value |
---|---|
June 30, 2019 | 247.28M |
March 31, 2019 | 243.86M |
December 31, 2018 | 227.53M |
September 30, 2018 | 200.58M |
June 30, 2018 | 197.80M |
March 31, 2018 | 197.36M |
December 31, 2017 | 151.73M |
September 30, 2017 | 145.59M |
June 30, 2017 | 139.50M |
March 31, 2017 | 135.73M |
December 31, 2016 | 139.74M |
September 30, 2016 | 132.85M |
June 30, 2016 | 63.87M |
March 31, 2016 | 58.59M |
December 31, 2015 | 56.52M |
September 30, 2015 | 52.56M |
June 30, 2015 | 48.46M |
December 31, 2014 | 20.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
124.01M
Minimum
Sep 2020
783.63M
Maximum
Dec 2023
575.68M
Average
710.81M
Median
Total Liabilities (Quarterly) Benchmarks
AtriCure Inc | 135.32M |
NeuroMetrix Inc | 1.333M |
Repligen Corp | 878.67M |
Teleflex Inc | 2.975B |
Perspective Therapeutics Inc | 22.71M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.121B |
Shareholders Equity (Quarterly) | 359.36M |
Debt to Equity Ratio | 1.585 |
Current Ratio | 6.258 |
Net Debt Paydown Yield | -0.05% |